We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Swiss drug giant Novartis AG (NOVN.VX) Thursday said drugs using technology licensed from Vectura Group PLC (VEC.LN) are scheduled for launch within the next few years, sending shares in the U.K...
Drug company Vectura Group PLC (VEC.LN) said Monday partner Novartis AG (NOVN.VX) began Phase III studies of QVA149, an experimental medicine for lung disease that combines Novartis's indacaterol...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 9.15 | 9.15 | 9.15 | 0 | 0 | CS |
4 | -0.39 | -4.08805031447 | 9.54 | 9.54 | 8.22 | 60 | 8.77875 | CS |
12 | -1.0895 | -10.640167977 | 10.2395 | 10.67 | 8.22 | 183 | 9.99417514 | CS |
26 | -1.44 | -13.597733711 | 10.59 | 10.8 | 8.22 | 310 | 9.68560227 | CS |
52 | -0.85 | -8.5 | 10 | 13.43 | 8.22 | 1067 | 11.99583657 | CS |
156 | -8.53 | -48.2466063348 | 17.68 | 22.782 | 8.22 | 1357 | 14.34681708 | CS |
260 | -14.43 | -61.1959287532 | 23.58 | 23.58 | 8.22 | 1235 | 14.41743714 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions